Isoform Oncology
Biotechnology Research • 
Stevenage, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | Stevenage Bioscience Catalyst, Stevenage, Hertfordshire SG1 2FX, GB |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Isoform Oncology
Sarah Morgan
Co-founder, CSO
About Isoform Oncology
Alternative splicing of proteins gives rise to an untapped wealth of tissue and disease-specific variants. Isoform Oncology is a new biotech exploiting isoform switching and alternative splicing for the development of new cancer biotherapeutics – designed to keep precision-medicine on target We are working for a future where “first-line” treatments work first time. On target. On Time. Every Time.
Isoform Oncology revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Isoform Oncology has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Isoform Oncology has never raised funding before.
Portugal
Germany
Netherlands
Australia
United States
United Arab EmiratesFrequently asked questions
4.8
40,000 users
